## VTR: Ventas, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -3.6% below STRENGTH zone (3.0-6.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Investment Management Corp of Ontario Boosts Holdings in Ventas, Inc. $VTR**
- Source: MarketBeat | 20251209T141545 | Somewhat-Bullish | Relevance: 100%
-  Investment Management Corp of Ontario significantly increased its stake in Ventas, Inc. by 1,019% in Q2, bringing its total holdings to 133,061 shares valued at approximately $8.4 million. This move is part of a broader trend of institutional investment, with firms collectively owning about 94% of Ventas stock. Despite recent insider selling and a high dividend payout ratio, analysts maintain a "Moderate Buy" rating for VTR, projecting an average target price of $78.40.

**2. Qube Research & Technologies Ltd Grows Holdings in Ventas, Inc. $VTR**
- Source: MarketBeat | 20251211T122646 | Somewhat-Bullish | Relevance: 99%
-  Qube Research & Technologies Ltd increased its stake in Ventas, Inc. by 24.6% in the second quarter, now holding 2,162,838 shares valued at $136.6 million. Ventas reported strong Q3 earnings, beating expectations with $0.88 EPS and $1.49 billion in revenue, and analysts have a positive outlook with an average price target of $78.40. Despite a high dividend payout ratio and significant insider stock sales recently, the company declared a quarterly dividend of $0.48 per share.

**3. Ventas Declares Quarterly Dividend of $0.48 Per Common Share**
- Source: Yahoo Finance Singapore | 20251210T220846 | Bullish | Relevance: 99%
-  Ventas, Inc. (NYSE: VTR) announced a quarterly dividend of $0.48 per common share. This dividend will be payable on January 15, 2026, to stockholders recorded as of December 31, 2025. Ventas is an S&P 500 real estate investment trust focusing on properties for the aging population.

**4. Ventas declares quarterly dividend of $0.48 per share By Investing.com**
- Source: Investing.com Canada | 20251210T223348 | Bullish | Relevance: 99%
-  Ventas, Inc. announced a quarterly dividend of $0.48 per common share, payable on January 15, 2026, to stockholders of record as of December 31, 2025. The real estate investment trust specializing in properties for aging populations has maintained dividend payments for 27 consecutive years, with a current annual dividend yield of 2.4%. This announcement follows recent positive third-quarter earnings, a successful $500 million senior notes offering, and an increased price target from Cantor Fitzgerald.

**5. Key Reasons to Add Ventas Stock to Your Portfolio Right Now**
- Source: TradingView | 20251211T140911 | Bullish | Relevance: 98%
- Ventas, Inc. (VTR) is a strong stock pick due to its diverse portfolio of healthcare real estate assets, which positioned it to benefit from rising healthcare spending and an aging population. The company's focus on its outpatient medical and research (OM&R) portfolio and accretive investments in research further solidify its growth prospects. Additionally, Ventas maintains a healthy balance sheet, suggesting continued financial strength and potential for stock growth.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Keybanc | $85 | $70 | +21% |
| 2025-11-25 | Wells Fargo | $88 | $80 | +10% |
| 2025-11-13 | Scotiabank | $80 | $74 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Overweight |
| 2025-11-13 | Scotiabank | main | Sector Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 17 ($4.24M) |
| Sells | 14 ($23.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (+2.5%)
- JPMORGAN CHASE & CO: 12.7% (+102.6%)
- Blackrock Inc.: 11.1% (+2.6%)
- State Street Corpora: 6.2% (+3.3%)
- FMR, LLC: 5.7% (+12.1%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.8% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $23M sold (14 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +13%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Analyst sentiment positive (3 raises, avg +13%). Insider selling cluster ($23.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.3B |
| Beta | 0.79 |
| 52W Range | $56.68 - $81.89 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 136.8 |
| Current P/E | 286.2 |
| YoY Growth | 109.3% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from -0.8% to -3.6% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.6pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). MACD histogram bearish (-0.58), momentum weakening. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.60% (CS: 7) | Weak |
| RSI_14 | 46.0 | Neutral |
| MACD Histogram | -0.58 | Bearish |
| vs SMA20 | 0.972x | Below |
| vs SMA50 | 1.035x | Above |
| vs SMA200 | 1.127x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $77.27
- **Stop Loss:** $74.47 (3.6% risk)
- **Target:** $80.07 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 492
- **Position Value:** $38,016.84
- **Portfolio %:** 38.02%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-11 (Est: $0.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.12 | +141.9% |
| 2025Q2 | $0.14 | $0.15 | +10.4% |
| 2025Q1 | $0.07 | $0.10 | +35.8% |
| 2024Q4 | $0.05 | $0.13 | +156.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*